Related Experiment Videos
Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation
T O Fischmann1, A Hruza, X D Niu
1Structural Chemistry Department, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA. thierry.fischmann@spcorp.com
Nature Structural Biology
|March 13, 1999
Summary
Structural insights into human endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) catalytic domains reveal conserved active sites and a novel zinc-binding site. These findings aid in designing selective inhibitors for nitric oxide synthase isozymes.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Nitric oxide synthases (NOS) are crucial enzymes involved in various physiological processes.
- Understanding the structural basis of NOS activity is key for therapeutic intervention.
- Selective inhibition of NOS isozymes (e.g., endothelial NOS and inducible NOS) is a significant therapeutic goal.
Purpose of the Study:
- To determine the high-resolution crystal structures of human endothelial nitric oxide synthase (eNOS) and human inducible nitric oxide synthase (iNOS) catalytic domains.
- To elucidate the binding modes of the arginine substrate and an inhibitor.
- To provide a structural basis for the design of isozyme-selective NOS inhibitors.
Main Methods:
- X-ray crystallography was employed to solve the crystal structures of eNOS and iNOS catalytic domains.
- Structures were determined in complex with arginine substrate (for eNOS) and S-ethylisothiourea (SEITU) inhibitor (for iNOS).
- High-resolution (2.4 Å for eNOS, 2.25 Å for iNOS) structural data were refined.
Main Results:
- The small molecules (arginine and SEITU) bind within a narrow cleft in the active site, interacting with heme and tetrahydrobiopterin.
- Both eNOS and iNOS active sites exhibit high similarity, with conserved residues including a key glutamate.
- An unexpected structural zinc ion was identified at the intermolecular interface, coordinated by four cysteine residues from adjacent monomers.
Conclusions:
- The high structural similarity between eNOS and iNOS active sites presents a challenge for selective inhibitor design.
- The identified conserved binding interactions and the novel zinc-binding site offer potential targets for developing isozyme-specific inhibitors.
- These structural findings provide critical insights for future drug discovery efforts targeting nitric oxide synthase pathways.